Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition
Makalish/iStock via Getty Images
I have been following the hereditary angioedema (‘HAE’) market with interest for some time now and have written about it in my articles on BioCryst Pharmaceuticals (BCRX).
Catabasis Pharmaceuticals (CATB) came to my attention…
